| Name | Title | Contact Details |
|---|
For more than 85 years, the Hendrick name has been the first name in healthcare in Abilene, Texas, and the Texas Midwest. As the first healthcare network to establish a true system of services, the Hendrick name reigns over a 522-bed medical center, a women’s center, rehabilitation hospital, cancer center and numerous other innovative services. Hendrick was the first hospital to permanently serve the Texas Midwest when its doors opened in 1924. During the Great Depression, it was the first hospital people of the Big Country area rallied behind to keep the doors open when money was scarce. Mr. and Mrs. Thomas Hendrick, for whom the institution was named, made the first major financial gift to the hospital. Through the years it has been the first in the area to offer specialized services, creating departments to fill needs such as physical medicine, nuclear medicine, spiritual care and much more.
Verana Health is a healthcare technology and analytics company entrusted by key medical associations to manage multi-specialty, real-world data at every stage of the analytics process—from entry to evidence. Anchored in ophthalmology, neurology, and urology, the Company acts as a linchpin in the healthcare data ecosystem, normalizing data and enhancing its clinical richness and quality to empower physicians and accelerate research for patients. By curating and applying advanced analytics to real-world clinical data, Verana Health helps life sciences partners enhance evidence generation, reinvent observational and prospective research, and drive innovations in specific disease areas.
UCP of Suffolk is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.
Lincoln Lutheran is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Lincoln Lutheran is based in Racine, WI. You can find more information on Lincoln Lutheran at www.llor.org